Pharmaceuticals

Freedom to Operate – Understanding the risks

Freedom to Operate – Understanding the risks   There are many factors to be considered for a project developing a new product or process, but Freedom to Operate should not be overlooked. What is Freedom to Operate? Freedom to Operate, or “FTO”, is the ability to carry out commercial plans without infringing third party Intellectual… Read more »

Prosecuting green patents around the world

Prosecuting green patents around the world The UK Intellectual Property Office (UK IPO) launched the Green Channel in 2009. The Green Channel is a scheme which allows applicants to request accelerated prosecution of patent applications directed to an invention which has an environmental benefit. Since the launch of the green channel in the UK, a… Read more »

EPO 2022 fee increases

EPO 2022 fee increases The European Patent Office (EPO) has announced a rise in many of its official fees to take effect from 1st April 2022. The announcement, published with full details of the new fees in the EPO Official Journal in January 2022, follows the Decision of the Administrative Council of 15th December 2021… Read more »

2022 updates to EPO Guidelines for Examination – Amendments to avoid contradictions between claims and description

1. Amendments to avoid contradictions between claims and description This forms part of a wider report on the 2022 updates to EPO Guidelines for Examination. There are some small but important changes to the guidelines on required changes to the description of a European patent application (Guidelines Part F, Chapter IV, section 4.3). Many EPO… Read more »

The Nagoya Protocol and the UK – are you compliant?

The Nagoya Protocol and the UK – are you compliant? The Nagoya Protocol has been in force in the UK since October 2015 and obliges users of genetic resources and traditional knowledge associated with genetic resources to comply with due diligence requirements before its ‘utilisation’. There is also an obligation to make a due diligence… Read more »

Government R&D Tax Credits Consultation

Deadline approaching for the Government R&D Tax Credits Consultation – your input needed for potential changes to RDEC and SME R&D Relief Government R&D Tax Credits Consultation: The UK government intends to raise investment in research and development to 2.4% of UK GDP by 2027 and wants to ensure that one of the key incentives for… Read more »

April AI Report 2021 – Trade marks

Trade marks in AI 2021 – Sarah Neil shares an update on the progress in the UK’s review of artificial intelligence and intellectual property   As we have mentioned in previous articles trade marks in AI are an important part of a strong portfolio in the protection of your AI business. The ever accelerating landscape… Read more »

Categories

Archives